Skip to main content
HCPCS J9289 · Level II · Part B drug

J9289: nivolumab (Opdivo Qvantig), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J9289

Billing unit
2 MG
Inj nivolumab 2 mg hyaluron
ASP payment limit
$27.989
October 2026; -0.5% vs July 2026
Practitioner MUE
600
MAI 3
OPPS status
SI G
APC 0848
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J9289 is the Level II code for Injection, nivolumab, 2 mg and hyaluronidase-nvhy, billed per 2 MG. The Medicare Part B ASP payment limit for October 2026 is $27.989 per billing unit, down 0.5% from July 2026. The practitioner MUE allows up to 600 units per date of service (MAI 3), so a full 600-unit day is $16,793.40 at the current limit. Under OPPS it carries status indicator G in APC 0848. J9289 is billed in units of 2 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names nivolumab: J9299 (Opdivo; billed per 1 mg). The ASP crosswalk maps 2 NDCs to it, sold as Opdivo Qvantig by E.R. Squibb & Sons, L.L.C. No current Billing and Coding Article lists J9289, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J9289 at $27.989 per 2 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $28.14 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J9289
QuarterPayment limitPerCoinsurance
October 2026$27.9892 MG20%
July 2026$28.142 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 2 NDCs from 1 labeler to J9289. Report the NDC in the claim's drug segment and bill the number of J9289 units that equals the quantity administered divided by 2 MG; the last column gives units per full package.

NDCs that crosswalk to J9289
NDCDrug nameLabelerPackage sizeBilling units / package
00003-3120-01Opdivo QvantigE.R. Squibb & Sons, L.L.C.2.5 × 1150
00003-6120-01Opdivo QvantigE.R. Squibb & Sons, L.L.C.5 × 1300

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J9289. For practitioners the limit is 600 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J9289 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services6003 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital6003 Date of Service Edit: ClinicalPrescribing Information
DME supplier6003 Date of Service Edit: ClinicalPrescribing Information

MUE for J9289 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J9289 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J9289 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J9289 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J9289 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J9289 carries status indicator G and is assigned to APC 0848, with a published national unadjusted payment of $27.989. Status G marks pass-through drug payment, which is time-limited.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J9289 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $27.99 per 2 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J9289 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J9289

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J9289

What does HCPCS code J9289 describe?

J9289 is defined by CMS as "Injection, nivolumab, 2 mg and hyaluronidase-nvhy". Each billing unit represents 2 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J9289 a CPT code?

No. J9289 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as nivolumab (Opdivo Qvantig); CPT codes are five-character codes maintained by the AMA. On a Part B claim J9289 reports the drug itself in 2 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J9289 in October 2026?

The ASP-based payment limit is $27.989 per 2 MG, with 20% beneficiary coinsurance. The July 2026 limit was $28.14. Commercial payers use their own fee schedules.

How many units of J9289 can be billed per day?

The practitioner Medically Unlikely Edit is 600 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J9289?

The October 2026 ASP crosswalk lists 2 NDCs from 1 labeler: Opdivo Qvantig (E.R. Squibb & Sons, L.L.C.). For example NDC 00003-3120-01 (package size 2.5) equals 150 billing units of J9289.

Does J9289 have NCCI bundling edits?

No active practitioner PTP pairs list J9289 as a column-1 or column-2 code in the v323r0 release.

J9289 vs J9299: what is the difference?

Both are HCPCS Level II codes whose descriptor names nivolumab. What sets J9299 apart: Opdivo; billed per 1 mg. J9289 is billed per 2 mg, limit $27.989, MUE 600; J9299 is billed per 1 mg, limit $34.191, MUE 480. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.